Article info
ORIGINAL ARTICLES
The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers – a study of the National Cancer Institute of Canada Clinical Trials Group
- Address correspondence and reprint requests to: Dr Amit Oza, MD, Department of Medical Oncology, Princess Margaret Hospital, 610 University Avenue, Suite, Toronto, Ontario M5G 2M9, Canada. Email: amit.oza{at}uhn.on.ca
Citation
The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers – a study of the National Cancer Institute of Canada Clinical Trials Group
Publication history
- First published June 1, 2004.
Online issue publication
March 06, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2004 Blackwell Publishing Ltd.